Dosing Vincristine in Dose-Adjusted EPOCH-R: To Cap or Not to Cap?

被引：4
|
作者：
Weis, Taylor M. [1 ]
Perissinotti, Anthony J. [1 ]
Nachar, Victoria R. [1 ]
Brown, Anna M. [1 ]
Phillips, Tycel J. [1 ]
Marini, Bernard L. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 31期
关键词：
THERAPY; CHEMOTHERAPY;
D O I：
10.1200/JCO.19.01259
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2952 / +
页数：2
相关论文
共 50 条
  • [1] Dosing Vincristine in Dose-Adjusted EPOCH-R: To Cap or Not to Cap? Reply
    Bartlett, Nancy L.
    Wilson, Wyndham H.
    Leonard, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31) : 2953 - +
  • [2] DOSE-ADJUSTED EPOCH-R: A RETROSPECTIVE STUDY IN THE TREATMENT OF AGGRESSIVE LYMPHOMAS
    Anichini, M.
    Kovalchuk, S.
    Puccini, B.
    Romano, I.
    Mazzoni, C.
    Galli, E.
    Bosi, A.
    HAEMATOLOGICA, 2019, 104 : 168 - 168
  • [3] Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R
    Lakhotia, Rahul
    Dunleavy, Kieron
    Abramson, Jeremy S.
    Link, Brian K.
    Powell, Bayard L.
    Melani, Christopher
    Lucas, Andrea N.
    Steinberg, Seth M.
    Friedberg, Jonathan W.
    Kahl, Brad S.
    Little, Richard F.
    Bartlett, Nancy L.
    Noy, Ariela
    Wilson, Wyndham H.
    Roschewski, Mark
    BLOOD ADVANCES, 2023, 7 (18) : 5320 - 5324
  • [4] Is dose-adjusted EPOCH-R the new standard for high-risk Burkitt lymphoma?
    Lim, Kenneth J. C.
    Filshie, Robin
    LANCET HAEMATOLOGY, 2023, 10 (12): : E942 - E943
  • [5] Dose-adjusted EPOCH-R plus venetoclax: a toxic bend in the road to improving R-CHOP?
    Chamuleau, Martine E. D.
    LANCET HAEMATOLOGY, 2021, 8 (11): : E781 - E783
  • [6] Dose-adjusted EPOCH-R: a feasible alternative for Burkitt lymphoma in resource-constrained settings
    Jindal, Nishant
    Jain, Arihant
    Lad, Deepesh
    Prakash, Gaurav
    Khadwal, Alka
    Malhotra, Pankaj
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (06) : e362 - e363
  • [7] Real-World Outcome of Dose-Adjusted EPOCH-R, a Single-Centre Experience
    Wong, Rachel
    Kansara, Roopesh R.
    BLOOD, 2020, 136
  • [8] Dose-adjusted EPOCH-R is a safe and well tolerated outpatient treatment regimen in double-hit lymphoma
    Nelles, Ricky
    Morris, Kirk
    Scott, Ashleigh
    Kennedy, Glenn
    INTERNAL MEDICINE JOURNAL, 2023, 53 (05) : 773 - 778
  • [9] Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas
    Gharwan, Helen
    Lai, Catherine
    Grant, Cliona
    Dunleavy, Kieron
    Steinberg, Seth M.
    Shovlin, Margaret
    Fojo, Tito
    Wilson, Wyndham H.
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1616 - 1624
  • [10] The role of rituximab and chemotherapy in aggressive B-cell lymphoma: A preliminary report of dose-adjusted EPOCH-R
    Wilson, WH
    Gutierrez, M
    O'Connor, P
    Frankel, S
    Jaffe, E
    Chabner, BA
    Grossbard, ML
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 41 - 47
12345